VDR and heart failure: Our finding that mice with a cardiomyocyte-specific deletion of the VDR exhibited more pronounced LV functional impairment after TAC than controls aligns with a post-hoc analysis of the EVITA (Effect of VITamin D on All-cause mortality in heart failure) trial.